Defining the role of CFTR channel blocker and ClC-2 activator in DNBS induced gastrointestinal inflammation.
Saudi Pharm J
; 29(4): 291-304, 2021 Apr.
Article
em En
| MEDLINE
| ID: mdl-33994824
CD, Crohn's disease; CFTR; CFTR, Cystic fibrosis transmembrane conductance regulator; CLC, Chloride Channel; ClC-2; DAI, Disease Activity Index; DC, Disease Control; DM, Diabetes Mellitus; DNBS, 2,4-Dinitrobenzene sulfonic acid; EtOH, Ethanol; G, Glibenclamide; GI, Gastrointestinal; GSH, Reduced Glutathione; Glibenclamide; H & E, Hematoxylin and eosin; IAEC, Institutional Animal Ethical Committee; IBD; IBD, Inflammatory Bowel Disease; L, Lubiprostone; Lubiprostone; MC, Mast cell; MDA, Malonaldehyde; MPO, Myeloperoxidase; NCEB, National Committee of Bio Ethics; PMS, Post-Mitochondrial Supernatant; RBC, Red blood cells; S, Sulfasalazine; SOD, Superoxide dismutase levels.; UC, Ulcerative colitis; WBC, White blood cells; i.p., Intraperitoneal Injection; p.o., Per Orally; s.c., Subcutaneous
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article